Delirium in the course of cancer treatment.
Delirium is a frequent complication of cancer treatment and is associated with a high incidence of morbidity and mortality. This article summarizes recent literature on the epidemiology, mechanisms, and treatment of delirium in the patient with cancer. As data continue to emerge on risk factors and pathophysiological mechanisms, recognition of the distinctive features of delirium in specific cancer populations could contribute to a better understanding of consciousness, cognition, perception, and behavior during medical illness.
Fann
Jesse R
JR
Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA 98195, USA. fann@u.washington.edu
Sullivan
Arthur K
AK
D000701:Analgesics, Opioid / Q000009:adverse effects; D003693:Delirium / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects; D009369:Neoplasms / Q000150:complications / Q000523:psychology* / Q000628:therapy; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D012307:Risk Factors; D013727:Terminal Care
D000701:Analgesics, Opioid